
Scientists confirm efficacy of cannabidiol in a type of genetic epilepsy
A study published in Epilepsia shows that pharmaceutical cannabidiol (CBD) can significantly reduce seizures in monogenic epilepsies, a rare and difficult-to-treat type of epilepsy. The research, conducted in Europe and Latin America, provides solid scientific evidence for the efficacy and safety of CBD in these genetic conditions.










